Researchers develop terahertz biosensor to detect skin cancer for early diagnosis
Results from the study could also be used for other forms of cancer and diseases
Read More
Tag: basal cell carcinoma
Sanofi, Regeneron’s Libtayo cleared for basal cell carcinoma
Libtayo is the first immunotherapy indicated for patients with advanced basal cell carcinoma
Read More
US approval for Libtayo in advanced basal cell carcinoma
First immunotherapy indicated for certain BCC patients
Read More
Roche’s skin cancer drug Erivedge pulled from CDF
Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute for Health and Care Excellence ruled that the drug was not a cost-effective treatment for skin cancer.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
